HST6 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target Antigen

The HST6 antibody likely refers to monoclonal antibodies (e.g., OKT6, Leu-6, or C56) targeting the human T6 antigen, a heterodimeric glycoprotein expressed on thymocytes and Langerhans cells. The T6 antigen consists of:

  • A 48 kDa heavy chain (distinct from HLA-A/B/C molecules)

  • A 12 kDa light chain (βt, unrelated to β2-microglobulin) .

These antibodies are critical for studying T-cell development and immune responses.

Biochemical Characterization

Key findings from studies of T6-targeting antibodies:

Antibody CloneTarget EpitopeMolecular Weight (Heavy Chain)Cross-Reactivity
OKT6T6 antigen48 kDaNone with murine TL antigens
Leu-6T6 antigen48 kDaBinds β2-microglobulin
C56T6 antigen48 kDaSimilar to OKT6
  • Specificity: These antibodies recognize a conserved epitope on the T6 heavy chain, with no polymorphism detected across individuals .

  • Structural Distinction: The T6 light chain (βt) differs from β2-microglobulin in isoelectric point and peptide composition .

Functional and Clinical Insights

  • Role in Immunity: The T6 antigen is implicated in early T-cell maturation and antigen presentation. Antibodies like OKT6 and Leu-6 are used to identify Langerhans cells and thymic epithelial cells .

  • Therapeutic Potential: While not directly cited for HST6, monoclonal antibodies targeting similar glycoproteins (e.g., anti-HHV-6B KH-1 and OHV-3) demonstrate neutralizing efficacy against viral infections, suggesting analogous applications for T6-targeting antibodies .

Research Applications

  • Diagnostic Use: T6 antibodies are employed in flow cytometry to isolate immune cell subsets (e.g., CD1a+ dendritic cells) .

  • Mechanistic Studies:

    • Neutralization Assays: Anti-T6 antibodies block receptor binding or membrane fusion in viral models, akin to HHV-6B-neutralizing antibodies .

    • Immunoprecipitation: Used to isolate T6 antigen complexes for structural analysis .

Unresolved Questions and Future Directions

  • Pathogenic Role: The T6 antigen’s involvement in autoimmune or neoplastic diseases remains underexplored.

  • Therapeutic Development: Humanized variants of T6 antibodies (e.g., chimeric formats) could enhance clinical utility, as seen with anti-HSV antibody HDIT101 .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
HST6 antibody; CAWG_02961 antibody; Alpha-factor-transporting ATPase antibody; EC 7.4.2.7 antibody; ATP-dependent permease HST6 antibody; STE6 homolog antibody
Target Names
HST6
Uniprot No.

Target Background

Protein Families
ABC transporter superfamily, Alpha-factor sex pheromone exporter (TC 3.A.1.206) family
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is HST6 protein and what organisms express it?

HST6 (UniProt Number: P53706) is a protein expressed in fungal species, particularly in Candida albicans strain WO-1 . It belongs to a family of proteins involved in various cellular processes in yeast. The protein is significant for researchers studying fungal biology and host-pathogen interactions. When designing experiments involving HST6, it's important to consider the specific strain of Candida, as protein expression levels and characteristics may vary between different fungal strains.

What types of HST6 antibodies are commercially available for research?

Currently, polyclonal HST6 antibodies are available for research applications. Specifically, rabbit polyclonal antibodies purified by antigen affinity are documented in the literature . These antibodies are unconjugated and designed for use in techniques including ELISA and Western blot applications. The commercially available antibodies are typically developed using recombinant Candida albicans (strain WO-1) HST6 protein as the immunogen .

How should HST6 antibodies be stored and handled in laboratory settings?

For optimal antibody performance and longevity, HST6 antibodies should be stored at -20°C or -80°C . When working with these antibodies, standard antibody handling protocols apply:

  • Minimize freeze-thaw cycles by preparing working aliquots

  • Thaw samples on ice or at 4°C

  • Use sterile technique when handling antibody solutions

  • Follow manufacturer's recommendations for dilution factors in specific applications

  • Monitor storage conditions regularly and avoid temperature fluctuations

What are the primary research applications for HST6 antibodies?

HST6 antibodies have been validated for ELISA and Western blot (WB) applications . They are particularly useful in research contexts investigating:

  • Candida albicans protein expression patterns

  • Host-pathogen interactions involving fungal species

  • Comparative studies of protein expression across different fungal strains

  • Investigating cellular responses to antifungal treatments

  • Characterizing fungal infection mechanisms in various experimental models

How can I validate the specificity of HST6 antibodies in my experimental system?

Validating antibody specificity is crucial for generating reliable research data. For HST6 antibodies, consider this comprehensive validation approach:

  • Positive and negative controls: Use the provided antigen (200μg) as a positive control and pre-immune serum (1ml) as a negative control .

  • Cross-reactivity testing: Test against multiple fungal species to determine specificity beyond Candida albicans.

  • Knockout/knockdown validation: If possible, use HST6 knockdown or knockout fungal strains to confirm antibody specificity.

  • Immunoprecipitation followed by mass spectrometry: This can confirm that the antibody is binding to the expected protein target.

  • Comparative analysis: Run parallel experiments with other antibodies targeting the same protein if available.

  • Peptide competition assay: Pre-incubate the antibody with purified HST6 protein before application in your assay to demonstrate binding specificity.

How can HST6 antibodies be used to study host-pathogen interactions in Candida infections?

HST6 antibodies can facilitate sophisticated analyses of Candida-host interactions through multiple methodological approaches:

  • Infection models analysis: Use the antibody to track HST6 expression during various stages of infection in cell culture or animal models.

  • Co-localization studies: Combine HST6 antibody with cellular markers to determine the spatial relationship between fungal proteins and host cellular components using confocal microscopy.

  • Temporal expression analysis: Apply the antibody in time-course experiments to monitor changes in HST6 expression during infection progression.

  • Interaction with immune cells: Study how HST6 expression changes when Candida interacts with different immune cell populations, particularly relevant as research has shown that Candida albicans can stimulate differentiation of hematopoietic stem and progenitor cells (HSPCs) in a TLR2-dependent manner .

  • Ex vivo tissue analysis: Apply the antibody to infected tissue samples to identify patterns of protein expression in the context of the host environment.

What considerations should be made when designing immunohistochemistry protocols with HST6 antibodies?

While the currently documented applications for HST6 antibodies are ELISA and Western blot , researchers adapting these antibodies for immunohistochemistry should consider:

  • Fixation optimization: Test multiple fixation methods (paraformaldehyde, methanol, acetone) to determine optimal antigen preservation.

  • Antigen retrieval: Systematically evaluate different retrieval methods (heat-induced, enzymatic) to maximize epitope accessibility.

  • Blocking optimization: Test various blocking reagents to minimize background while preserving specific signal.

  • Dilution series: Perform careful titration experiments to determine optimal antibody concentration.

  • Detection system selection: Compare chromogenic versus fluorescent detection systems based on your research questions.

  • Controls: Include appropriate positive controls (known HST6-expressing Candida samples), negative controls (samples without the target), and technical controls (primary antibody omission).

How can HST6 antibodies contribute to research on antifungal resistance mechanisms?

HST6 antibodies can provide valuable insights into antifungal resistance through several methodological approaches:

  • Protein expression monitoring: Quantify changes in HST6 expression in resistant versus susceptible strains using Western blot analysis.

  • Subcellular localization studies: Determine if HST6 localization changes in response to antifungal exposure using fractionation followed by immunoblotting.

  • Proteomics integration: Use HST6 antibodies for immunoprecipitation followed by mass spectrometry to identify interaction partners that may change during resistance development.

  • Time-course analysis: Monitor dynamic changes in HST6 expression during acquisition of resistance using the antibody in Western blot applications.

  • Comparative analysis across strains: Apply the antibody to analyze HST6 expression across clinical isolates with varying resistance profiles.

What are the optimal conditions for using HST6 antibodies in Western blot applications?

For Western blot applications with HST6 antibodies, consider the following protocol optimizations:

  • Sample preparation: For fungal samples, use glass bead disruption in the presence of protease inhibitors to ensure complete protein extraction.

  • Protein loading: Load 20-50μg of total protein per lane, with precise quantification using Bradford or BCA assays.

  • Gel percentage: Use 10-12% SDS-PAGE gels for optimal resolution of the HST6 protein.

  • Transfer conditions: Optimize transfer conditions based on protein size, typically using semi-dry transfer at 15V for 30 minutes or wet transfer at 100V for 1 hour.

  • Blocking: Use 5% non-fat dry milk in TBST for 1 hour at room temperature.

  • Primary antibody: Dilute HST6 antibody according to manufacturer specifications, typically 1:1000 to 1:2000, and incubate overnight at 4°C.

  • Secondary antibody: Use anti-rabbit HRP-conjugated secondary antibody at 1:5000 dilution for 1 hour at room temperature.

  • Detection: Apply enhanced chemiluminescence (ECL) substrates and image using a digital imaging system.

How can HST6 antibodies be utilized in studying cross-species conservation of fungal proteins?

To investigate evolutionary conservation using HST6 antibodies:

  • Comparative Western blot: Apply the antibody against protein extracts from multiple fungal species to assess cross-reactivity.

  • Epitope mapping: Determine the specific epitope(s) recognized by the antibody and analyze sequence conservation of these regions across species.

  • Functional domain analysis: Use the antibody to determine if conserved domains show differential expression or modification patterns across species.

  • Phylogenetic correlation: Correlate antibody reactivity patterns with established phylogenetic relationships between fungal species.

  • Structural homology investigation: Combine antibody-based detection with structural prediction tools to analyze functional conservation.

HST6 Antibody Technical Specifications

ParameterSpecification
Article NumberCSB-PA347428XA01CZE-2
Clone TypePolyclonal
HostRabbit
ImmunogenRecombinant Candida albicans (strain WO-1) HST6 protein
ApplicationsELISA, Western blot
Species ReactivityFungi, yeast
IsotypeIgG
Purification MethodAntigen Affinity
Storage Conditions-20°C or -80°C
UniProt NumberP53706
Size2mg
Components200μg antigens (positive control), 1ml pre-immune serum (negative control), Purified rabbit polyclonal antibodies

Table 1: Technical specifications of commercially available HST6 antibody .

What are common issues encountered when using HST6 antibodies and how can they be resolved?

Researchers may encounter several challenges when working with HST6 antibodies:

  • High background in Western blots

    • Solution: Optimize blocking conditions (increase blocking time, try different blocking agents), increase washing duration and frequency, and reduce primary antibody concentration.

  • Weak or absent signal

    • Solution: Ensure adequate protein loading, optimize protein extraction from fungal cells (consider different lysis buffers), increase antibody concentration, extend incubation time, or enhance detection sensitivity.

  • Non-specific bands

    • Solution: Increase antibody specificity through more stringent washing, adjust antibody dilution, or perform peptide competition assays to identify specific bands.

  • Batch-to-batch variability

    • Solution: Validate each new antibody lot against a reference sample, maintain consistent experimental conditions, and consider creating a large stock of a validated lot for long-term studies.

  • Sample degradation

    • Solution: Use fresh samples when possible, add protease inhibitors during extraction, maintain samples at appropriate temperatures, and minimize freeze-thaw cycles.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.